Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This project aims to evaluate the efficacy and safety of oral taurine supplementation
combined with PD-1 inhibitor (serplulimab) and chemotherapy in inducing systemic CD8+ T cell
responses and achieving improved gastric cancer patient outcomes than with serplulimab and
chemotherapy alone.